Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Authors: Deen J Lopez AL Kanungo S Wang XY Anh DD Tapia M Grais RF
Journal Reference: Human vaccines & immunotherapeutics 2018 02 01; 14(2); 495-499. doi: 10.1080/21645515.2017.1403705. Epub 2017 12 21
Rotavirus rotavirus vaccination rotavirus vaccine
eng

Abstract

There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.